Skip to main content
SpringerLink
Log in

Significance and usefulness of cancer registries

  • Review Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

A cancer registry is an organization set up for the collection, storage, analysis, and interpretation of data on people with cancer. There are three types of cancer registry: hospital-based, population-based, and nationwide site-specific. A cancer registry is essential for planning and evaluating cancer control activities, including clinical practices. We describe the significance and usefulness of cancer registries, with examples of assessments of the size of the cancer problem (i.e., incidence, mortality rates, and survival of cancer patients), assessments of the effects of cancer control programs, feedback to clinicians, and the building and testing of hypotheses of cancer etiology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkin DM, Wagner G, Muirc (eds) (1985) The role of the registry in cancer control. International Agency for Research on Cancer (IARC) Scientific Publications No. 66. IARC, Lyon

    Google Scholar 

  2. Parkin DM, Whelan SL, Ferlay J, et al. (1997) Cancer incidence in five continents. Vol. VII. International Agency for Research on Cancer Scientific Publications No. 143. IARC, Lyon

    Google Scholar 

  3. Oshima A (ed) (1998) Survey of population-based cancer registries in Japan in 1997 (in Japanese). Japan Public Health Association, Tokyo

    Google Scholar 

  4. Fujimoto I, Hanai A, Hiyama T, et al. (eds) Cancer incidence and mortality in Osaka 1963–1989 (1993) Osaka Foundation for Prevention of Cancer and Circulatory Diseases, Osaka

    Google Scholar 

  5. Oshima A, Tsukuma H, Ajiki W, et al. (eds) (1998) Survival of cancer patients in Osaka 1975–89. Osaka Foundation for Prevention of Cancer and Circulatory Diseases, Osaka

    Google Scholar 

  6. Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan, 1985–89 (1998) Re-estimation based on data from eight cancer registries. Jpn J Clin Oncol 28:54–67

    Google Scholar 

  7. Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan in 1992–1993 (1998) Estimates based on data from population-based cancer registries. Jpn J Clin Oncol 28:641–647

    Google Scholar 

  8. Fujimoto I, Hanai A, Tominaga S, Kuroishi T (1988) Future predictions of cancer incidence in Japan (in Japanese). Jpn J Cancer Clin 34:1911–1916

    Google Scholar 

  9. Tsukuma H, Kitagawa T, Hanai A, et al. (1992) Incidence of cancer predictions in Japan up to the year 2015 (in Japanese with English abstract). Jpn J Cancer Clin 38:1–10

    Google Scholar 

  10. Kitagawa T, Tsukuma H, Kuroishi T, Hanai A (1996) Future prediction of cancer incidence in Japan based on the incidence data 1975-89 (in Japanese). Kosei no Shihyo (Indices of Health and Welfare) 43:10–18

    Google Scholar 

  11. Ajiki W, Tsukuma H, Oshima A (1998) Time trends of survival for patients with stomach, lung and breast cancers, and factors attributed to their improvement. Jpn J Cancer Res 89 (Suppl); 253

    Google Scholar 

  12. Woods WG, Tuchman M, Robison LL, et al. (1996) A populationbased study of the usefulness of screening for neuroblastoma. Lancet 384:1682–1687

    Google Scholar 

  13. Ajiki W, Tsukuma H, Oshima A (1998) Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan. Cancer Causes Control (in press)

  14. Oshima A, Sakagami F, Hanai A, Fujimoto I (1979) A method of record linkage. Environ Health Perspect 32:537–546

    Google Scholar 

  15. Murakami R, Tsukuma H, Ubukata T, et al. (1990) Estimation of validity of mass screening program for gastric cancer in Osaka, Japan. Cancer 65:1255–1260

    Google Scholar 

  16. Sobue T, Suzuki T, Matsuda M (1991) Sensitivity and specificity of lung cancer screening in Osaka, Japan. Jpn J Cancer Res 82:1069–1076

    Google Scholar 

  17. Fujita M, Okayama Y, Murakami R, et al. (1995) Sensitivity, specificity, and positive predictivity of the immunological fecal occult blood test (RPHA) in mass screening for colorectal cancers (in Japanese). J Gastroenterol Mass Survey 33:477–485

    Google Scholar 

  18. Murakami R, Tsukuma H, Kanamori S, et al. (1990) Natural history of colorectal polyps and the effect of polypectomy on occurrence of subsequent cancer. Int J Cancer 46:159–164

    Google Scholar 

  19. Imai Y, Kawata S, Tamura S, et al. (1998) Relation of interferon therapy for hepatocellular carcinoma in patients with chronic hepatitis C. Ann Intern Med 129:94–99

    Google Scholar 

  20. Oshima A, Tsukuma H, Hiyama T, et al. (1984) Follow-up study of HBs Ag-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer 34:775–779

    Google Scholar 

  21. Tatsuta M, Iishi H, Nakaizumi A, et al. (1993) Fundal atrophic gusfritis as a risk factor for gastric cancer. Int J Cancer 53:70–74

    Google Scholar 

  22. Kawashima T (1991) Epidemiological study on the risk of gastric cancer for patients with duodenal ulcer (in Japanese with English abstract). Jpn J Gastroenterol 88:1161–1167

    Google Scholar 

  23. Hiyama T, Fujimoto I, Hanai A (1985) Occurrence of second primary cancers among patients with cervical cancer in Osaka, Japan. Natl Cancer Inst Monogr 69:181–184

    Google Scholar 

  24. Fujimoto I, Hanai A, Murakami R, Yoshitake J (1985) Association of second primary leukemias with the method of treatment of the first primary cancer. Jpn J Clin Oncol 15 Suppl 1):265–270

    Google Scholar 

  25. Murakami R, Hiyama T, Hanai A, Fujimoto I (1987) Second primary cancers following female breast cancer in Osaka, Japan. A population-based cohort study. Jpn J Clin Oncl 17:293–302

    Google Scholar 

  26. Hiyama T, Hanai A, Fujimoto I (1991) Second primary cancer after diagnosis of stomach cancer in Osaka, Japan. Jpn J Cancer Res 82:762–770

    Google Scholar 

  27. Tanaka H, Hiyama T, Hanai A, Fujimoto I (1991) Second primary cancers following colon and rectal cancer in Osaka, Japan. Jpn J Cancer Res 82:1356–1365

    Google Scholar 

  28. Tsukuma H, Fujimoto I, Hanai A, et al. (1994) Incidence of second primary cancers in Osaka residents, Japan with special reference to cumulative and relative risks. Jpn J Cancer Res 85:339–345

    Google Scholar 

  29. Greenwald P, Kramer BS, Weed DL (eds) (1995) Cancer prevention and control. Marcel Dekker, New York

    Google Scholar 

  30. Schottnfeld D, Fruumeni JP (eds) (1996) Cancer epidemiology and prevention., 2nd edn. Oxford University Press, New York

    Google Scholar 

  31. Tsukuma H (1996) Epidemiology. In: Ariyoshi H, Saijo N, Sasaki Y, Fukuoka M, Watanabe T (eds). Clinical oncology (in Japanese). Gan to Kagakuryohosha, Tokyo, chapter 13, pp 209–226

    Google Scholar 

  32. Okamoto N, Murata M, Sasaki T, et al. (1996) Five-year relative survival rates of patients with cancer at cancer center hospitals in Japan (in Japanese with English abstract). Jpn J Cancer Clin 42:1183–1188

    Google Scholar 

  33. Hiyama T, Sato T, Yoshino K, et al. (1992) Second primary cancer following laryngeal cancer with special reference to smoking habits. Jpn J Cancer Res 83:334–339

    Google Scholar 

  34. Kinoshita N, Koyama Y, Yoshino K, et al. (1997) Second primary cancers occurring in patients with cancers of the mouth and mesohypo pharynx in Japan (in Japanese with English abstract). Jpn J Public Health 44:201–206

    Google Scholar 

  35. Ajiki W, Tsukuma H, Oshima A, Tanaka H (1997) Multiple primary cancer in patients with laryngeal cancer — effect of smoking habits after treatment (in Japanese). J Epidemiol 7 (Suppl): 86

    Google Scholar 

  36. Watanabe S, Tominaga S, Kakizoe T (eds) (1995) Cancer treatment and survival. Site-specific registries in Japan. Monograph on cancer research No. 43. Japan Scientific Societies Press Tokyo

    Google Scholar 

  37. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. In: Watanabe S, Tominaga S, Kakizoe T (eds) (1995) Cancer treatment and survival. Site-specific registries in Japan. Japan Scientific Societies Press Tokyo, pp 81–95

    Google Scholar 

  38. Muir CS, Demaret E, Boyle P. The cancer registry in cancer control. Overview. In: Parkin DM, Wagner G, Muir C (eds) (1985) The role of the registry in cancer control. IARC, Lyon, chapter 2, pp 13–26

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cancer Control and Stastistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, 537-8511, Higashinari-ku, Osaka, Japan

    A. Oshima, W. Ajiki, H. Tanaka & H. Tsukuma

Authors
  1. A. Oshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Ajiki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Tsukuma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Oshima.

About this article

Cite this article

Oshima, A., Ajiki, W., Tanaka, H. et al. Significance and usefulness of cancer registries. Int J Clin Oncol 3, 343–350 (1998). https://doi.org/10.1007/BF00539211

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00539211

Key words

Search

Navigation